Among responder CD180-positive CLL cases, the dichotomous activation of AKT or p38MAPK in CLL cells following CD180 ligation, respectively, corresponds with survival or apoptosis (Porakishvili et al. 2015). This evidence concerns the gene CD180 and B-cell chronic lymphocytic leukemia.